Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yesim Dargaud

Showing results (11-20 of 128) with videos related to

Pageof 13
Sort By:
Journal of Thrombosis and Haemostasis : JTH|August 30, 2020
Response to "Studies on hemostasis in COVID-19 deserve careful reporting of the laboratory methods, their significance and their limitation": Don't throw the baby out with the bathwaterChristophe Nougier, Remi Benoit, Yesim Dargaud
Blood|September 3, 2010
Prospective assessment of thrombin generation test for dose monitoring of bypassing therapy in hemophilia patients with inhibitors undergoing elective surgeryYesim Dargaud, Anne Lienhart, Claude Negrier
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 16, 2025
The Mirage of Factor Equivalence: Examining the Complexities of Non-Factor Therapies in HaemophiliaYesim Dargaud, Arianna Colombo, Maria Elisa Mancuso
British Journal of Clinical Pharmacology|January 12, 2019
Dose tailoring of human cell line-derived recombinant factor VIII simoctocog alfa: Using a limited sampling strategy in patients with severe haemophilia AXavier Delavenne, Yesim Dargaud, Edouard Ollier, et al.
Thrombosis Research|October 24, 2022
Effectiveness of individualized management using WILFACTIN® in patients with von Willebrand disease during surgical procedures: A single-center studyLucia Rugeri, Rémi Benoit, Stéphanie Desage, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 27, 2020
A new paradigm for personalized prophylaxis for patients with severe haemophilia AXavier Delavenne, Edouard Ollier, Anne Lienhart, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 28, 2023
Specialist training in thrombosis and haemostasis across Europe: From aspirations to actionsYesim Dargaud, Pierre Fontana, Pierre Fenaux, et al.
Journal of Thrombosis and Haemostasis : JTH|February 28, 2024
"Women with severe postpartum hemorrhage have a decreased endogenous thrombin potential before delivery": replyClaire de Moreuil, Yesim Dargaud, Brigitte Pan-Petesch
Anesthesiology|March 22, 2013
Case scenario: management of trauma-induced coagulopathy in a severe blunt trauma patientJean-Stephane David, Anne Godier, Yesim Dargaud, et al.
Thrombosis and Haemostasis|March 30, 2007
Haemophilia patients exhibit prolonged coagulation time but normal lag time of thrombin generation test: are these results really discordant?Yesim Dargaud, Jean Claude Bordet, Stéphanie Francillon, et al.
Pageof 13

Showing results (11-20 of 128) with videos related to

Sort By:
Pageof 13
Journal of Thrombosis and Haemostasis : JTH|August 30, 2020
Response to "Studies on hemostasis in COVID-19 deserve careful reporting of the laboratory methods, their significance and their limitation": Don't throw the baby out with the bathwaterChristophe Nougier, Remi Benoit, Yesim Dargaud
Blood|September 3, 2010
Prospective assessment of thrombin generation test for dose monitoring of bypassing therapy in hemophilia patients with inhibitors undergoing elective surgeryYesim Dargaud, Anne Lienhart, Claude Negrier
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 16, 2025
The Mirage of Factor Equivalence: Examining the Complexities of Non-Factor Therapies in HaemophiliaYesim Dargaud, Arianna Colombo, Maria Elisa Mancuso
British Journal of Clinical Pharmacology|January 12, 2019
Dose tailoring of human cell line-derived recombinant factor VIII simoctocog alfa: Using a limited sampling strategy in patients with severe haemophilia AXavier Delavenne, Yesim Dargaud, Edouard Ollier, et al.
Thrombosis Research|October 24, 2022
Effectiveness of individualized management using WILFACTIN® in patients with von Willebrand disease during surgical procedures: A single-center studyLucia Rugeri, Rémi Benoit, Stéphanie Desage, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 27, 2020
A new paradigm for personalized prophylaxis for patients with severe haemophilia AXavier Delavenne, Edouard Ollier, Anne Lienhart, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 28, 2023
Specialist training in thrombosis and haemostasis across Europe: From aspirations to actionsYesim Dargaud, Pierre Fontana, Pierre Fenaux, et al.
Journal of Thrombosis and Haemostasis : JTH|February 28, 2024
"Women with severe postpartum hemorrhage have a decreased endogenous thrombin potential before delivery": replyClaire de Moreuil, Yesim Dargaud, Brigitte Pan-Petesch
Anesthesiology|March 22, 2013
Case scenario: management of trauma-induced coagulopathy in a severe blunt trauma patientJean-Stephane David, Anne Godier, Yesim Dargaud, et al.
Thrombosis and Haemostasis|March 30, 2007
Haemophilia patients exhibit prolonged coagulation time but normal lag time of thrombin generation test: are these results really discordant?Yesim Dargaud, Jean Claude Bordet, Stéphanie Francillon, et al.
Pageof 13